Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trialLisse Decraecker, Guy E. Boeckxstaens, David P. Hirsch et al.|Gut|2024Cited by 37